|
mutLBSgeneDB |
| |
| |
| |
| |
| |
| |
|
| Gene summary for GRIK1 |
 Gene summary |
| Basic gene Info. | Gene symbol | GRIK1 |
| Gene name | glutamate receptor, ionotropic, kainate 1 | |
| Synonyms | EAA3|EEA3|GLR5|GLUR5|GluK1 | |
| Cytomap | UCSC genome browser: 21q22.11 | |
| Type of gene | protein-coding | |
| RefGenes | NM_000830.3, NM_175611.2, | |
| Description | excitatory amino acid receptor 3gluR-5glutamate receptor 5glutamate receptor ionotropic, kainate 1 | |
| Modification date | 20141207 | |
| dbXrefs | MIM : 138245 | |
| HGNC : HGNC | ||
| Ensembl : ENSG00000171189 | ||
| HPRD : 00693 | ||
| Vega : OTTHUMG00000078879 | ||
| Protein | UniProt: P39086 go to UniProt's Cross Reference DB Table | |
| Expression | CleanEX: HS_GRIK1 | |
| BioGPS: 2897 | ||
| Pathway | NCI Pathway Interaction Database: GRIK1 | |
| KEGG: GRIK1 | ||
| REACTOME: GRIK1 | ||
| Pathway Commons: GRIK1 | ||
| Context | iHOP: GRIK1 | |
| ligand binding site mutation search in PubMed: GRIK1 | ||
| UCL Cancer Institute: GRIK1 | ||
| Assigned class in mutLBSgeneDB | B: This gene belongs to targetable_mutLBSgenes. | |
| Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
| GO ID | GO Term | PubMed ID | GO:0035235 | ionotropic glutamate receptor signaling pathway | 9335499 |
| Top |
| Ligand binding site mutations for GRIK1 |
| Lollipop-style diagram of mutations at LBS in amino-acid sequence. We represented ligand binding site mutations only. (You can see big image via clicking.)  : non-synonymous mutation on LBS, Circle size denotes number of samples. |
 |
| Cancer type specific mutLBS sorted by frequency |
| LBS | AAchange of nsSNV | Cancer type | # samples | S756 | E758Q | BLCA | 1 | T533 | T535N | HNSC | 1 | P531 | P531L | LUAD | 1 | Y504 | A506D | LUAD | 1 | E753 | S754Y | OV | 1 | Y779 | G780R | UCEC | 1 |
| cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma. |
| Top |
| Protein structure related information for GRIK1 |
| Relative protein structure stability change (ΔΔE) using Mupro 1.1 Mupro score denotes assessment of the effect of mutations on thermodynamic stability. (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability) |
 : nsSNV at non-LBS : nsSNV at LBS |
 |
| nsSNVs sorted by the relative stability change of protein structure by each mutation Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene. |
| LBS | AAchange of nsSNV | Relative stability change | S756 | E758Q | -1.9233286 | T533 | T535N | -1.7968963 | Y504 | A506D | -1.0988112 | E753 | S754Y | -0.96553071 | P531 | P531L | -0.59552697 | Y779 | G780R | -0.4380026 |
| (MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132) |
| Structure image for GRIK1 from PDB |
| Top |
| Differential gene expression and gene-gene network for GRIK1 |
| Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types |
| Differential co-expressed gene network based on protein-protein interaction data (CePIN) |
| Top |
| Top |
| Phenotype information for GRIK1 |
| Gene level disease information (DisGeNet) |
| Disease ID | Disease name | # PubMed | Association type |
| umls:C0036572 | Seizures | 3 | Biomarker |
| Mutation level pathogenic information (ClinVar annotation) |
| Allele ID | AA change | Clinical significance | Origin | Phenotype IDs |
| Top |
| Pharmacological information for GRIK1 |
| Gene expression profile of anticancer drug treated cell-lines (CCLE) Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient. |
 |
| Gene-centered drug-gene interaction network |
 |
| Drug information targeting mutLBSgene (Approved drugs only) |
| Drug status | DrugBank ID | Name | Type | Drug structure |
| Nutraceutical | DB00142 | L-Glutamic Acid | Small molecule |  |
| Approved | DB00273 | Topiramate | Small molecule |  |
| Gene-centered ligand-gene interaction network |
 |
| Ligands binding to mutated ligand binding site of GRIK1 go to BioLip |
| Ligand ID | Ligand short name | Ligand long name | PDB ID | PDB name | mutLBS |
| Top |
| Conservation information for LBS of GRIK1 |
| Multiple alignments for P39086 in multiple species |
| LBS | AA sequence | # species | Species |
 |
Copyright © 2016-Present - The University of Texas Health Science Center at Houston |